Success Metrics

Clinical Success Rate
80.0%

Based on 12 completed trials

Completion Rate
80%(12/15)
Active Trials
12(32%)
Results Posted
17%(2 trials)
Terminated
3(8%)

Phase Distribution

Ph phase_2
2
5%
Ph not_applicable
19
50%
Ph phase_3
2
5%
Ph phase_1
1
3%

Phase Distribution

1

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution24 total trials
Phase 1Safety & dosage
1(4.2%)
Phase 2Efficacy & side effects
2(8.3%)
Phase 3Large-scale testing
2(8.3%)
N/ANon-phased studies
19(79.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

12 of 15 finished

Non-Completion Rate

20.0%

3 ended early

Currently Active

12

trials recruiting

Total Trials

38

all time

Status Distribution
Active(15)
Completed(12)
Terminated(3)
Other(8)

Detailed Status

Completed12
unknown8
Recruiting7
Active, not recruiting5
Terminated3
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
38
Active
12
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (4.2%)
Phase 22 (8.3%)
Phase 32 (8.3%)
N/A19 (79.2%)

Trials by Status

active_not_recruiting513%
enrolling_by_invitation13%
not_yet_recruiting25%
completed1232%
terminated38%
unknown821%
recruiting718%

Recent Activity

Clinical Trials (38)

Showing 20 of 38 trialsScroll for more
NCT06636526

The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).

Recruiting
NCT07352748

Exploiting Heterogeneity in Hormone Therapy Response to Reveal Early Determinants of Drug Resistance in Advanced PCa

Active Not Recruiting
NCT06391034Phase 2

Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer

Recruiting
NCT03383016

Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE)

Active Not Recruiting
NCT07296042Not Applicable

Targeted And Perilesional Or Systematic Biopsy In Prostate Cancer

Not Yet Recruiting
NCT07296510

Is it Feasible to Use Data Obtained Through a Three-Dimensional Reconstructed Image to Assist in Prostate Targeted Biopsy?

Completed
NCT02485379Not Applicable

Assessment of Prostate MRI Before Prostate Biopsies

Completed
NCT07271017Phase 1

Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe

Recruiting
NCT03158922

The BARCODE 1 Pilot Study

Active Not Recruiting
NCT00261456

The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer

Active Not Recruiting
NCT06986083Phase 3

A Study of Changes to Prostate Procedures

Recruiting
NCT03857477

The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.

Active Not Recruiting
NCT06505356Not Applicable

Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association with Disease Stage

Enrolling By Invitation
NCT06507462

A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3

Completed
NCT06612047

Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer

Recruiting
NCT06691438Not Applicable

Evaluation of the Effect on Pain of Attentional Diversion Associated with Hypnotic Induction by Virtual Reality (VRH) in Perioperative Prostate Biopsies Under Local Anesthesia:

Not Yet Recruiting
NCT03507725Not Applicable

Early Staged Consent Before Prostate Biopsy

Completed
NCT04183699Not Applicable

Optimizing the Number of Systematic COres During a MRI Target Biopsy

Recruiting
NCT03632655Not Applicable

A Prospective, Randomized Trial Comparing Office-based MR-guided Prostate Biopsy Approaches

Terminated
NCT04599218Not Applicable

MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer

Recruiting

Drug Details

Intervention Type
PROCEDURE
Total Trials
38